Bank of New York Mellon’s SBC Medical Group SBC Stock Holding History
Bought
Maintained
Sold
Other funds holding SBC
LK
SS
N
CPBTD
WN
Bank of New York Mellon's SBC Position: Q2 2026 in Review
Bank of New York Mellon increased its SBC Medical Group (SBC) stake by 165% in Q2 2026, buying an estimated $57K and bringing the position to 26,991 shares worth $83.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4210.
Bank of New York Mellon first reported a position in SBC in Q1 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold SBC as of Q2 2026.
- Bank of New York Mellon held 26,991 shares of SBC Medical Group worth $83.1K as of Q2 2026.
- Bank of New York Mellon bought 16,811 SBC Medical Group shares in Q2 2026, an estimated $57K.
- SBC Medical Group made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4210 holding.
- Bank of New York Mellon first reported a position in SBC Medical Group in Q1 2026 and has held it in 2 quarters since.
- 29 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.